Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Generation Bio Co (NASDAQ: GBIO) closed the day trading at $1.02 down -6.42% from the previous closing price of $1.09. In other words, the price has decreased by -$6.42 from its previous closing price. On the day, 2.92 million shares were traded. GBIO stock price reached its highest trading level at $1.1 during the session, while it also had its lowest trading level at $1.0.
Ratios:
For a better understanding of GBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.34 and its Current Ratio is at 6.34. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.79.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’24 when Paone Antoinette sold 6,719 shares for $2.74 per share. The transaction valued at 18,410 led to the insider holds 13,807 shares of the business.
Paone Antoinette sold 2,445 shares of GBIO for $3,961 on Jan 02 ’24. The CHIEF OPERATING OFFICER now owns 5,828 shares after completing the transaction at $1.62 per share. On Jan 02 ’24, another insider, Samayoa Phillip, who serves as the CHIEF STRATEGY OFFICER of the company, sold 2,445 shares for $1.62 each. As a result, the insider received 3,961 and left with 107,256 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GBIO now has a Market Capitalization of 68128656 and an Enterprise Value of -22862322. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.67 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at -1.23 whereas that against EBITDA is 0.248.
Stock Price History:
Over the past 52 weeks, GBIO has reached a high of $4.65, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -43.96%, while the 200-Day Moving Average is calculated to be -61.79%.
Shares Statistics:
Over the past 3-months, GBIO traded about 164.56K shares per day on average, while over the past 10 days, GBIO traded about 299190 shares per day. A total of 66.75M shares are outstanding, with a floating share count of 42.51M. Insiders hold about 36.35% of the company’s shares, while institutions hold 66.03% stake in the company. Shares short for GBIO as of 1732838400 were 1528113 with a Short Ratio of 9.29, compared to 1730332800 on 1657497. Therefore, it implies a Short% of Shares Outstanding of 1528113 and a Short% of Float of 3.82.
Earnings Estimates
The current rating of Generation Bio Co (GBIO) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.31 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$1.75 and -$1.88 for the fiscal current year, implying an average EPS of -$1.81. EPS for the following year is -$0.66, with 2.0 analysts recommending between -$0.31 and -$1.01.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for GBIO’s current fiscal year. The highest revenue estimate was $23.26M, while the lowest revenue estimate was $15.7M, resulting in an average revenue estimate of $18.14M. In the same quarter a year ago, actual revenue was $5.9M